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 Abstract. 
During the 2009-2015 time period, 127 patients with complicated forms of chronic pancreatitis (CP) underwent 
surgical treatment at the Department of General Surgery of the Ivano-Frankivsk Regional Clinical Hospital. CP was 
accompanied by biliary hypertension (BH) in 39 (30.7%) patients. 14 (11.1%) patients developed BH with concomitant 
chronic duodenal obstruction (CDO), and in 4 (3.1%) patients a combination of BH+CDO and local venous hypertension 
(VH) of the vessels in the pancreatobiliary area was found. The analyzed group included 36 (92.3%) men and 3 (7.7%) 
women at the age of 21 to 60 years. In all 39 patients tubular stenosis of the intrapancreatic part of the choledoch was the 
morphological substrate of BH due to fibrose-degenerative changes in the pancreatic head; in 9 (23.1%) patients it was 
combined with cysts of the pancreatic head. In 28 (71.7%) patients, BH had clinical signs (ochrodermia and mucosal 
icterus, hyperbilirubinemia), and in 11 (28.9%) patients BH was asymptomatic and was diagnosed only by means of 
ultrasonography (USG) and computed tomography (CT) (tubular stenosis and dilation of the suprapancreatic segment of 
the common bile duct 0.7 cm to 1.3 – 1.5 cm). In 3 (7.6%) patients, BH was accompanied by the manifestations of 
cholangitis. All patients with CP complicated by BH underwent surgical treatment. Drainage, resection, and combined 
surgical interventions were used. In 17 (43.5%) patients CP complicated by BH was the result of acute pancreatitis (1 to 
10 years ago), 14 of them underwent surgeries: 2 patients – laparoscopic drainage of the enzymatic peritonitis, 5 patients 
– laparotomy, drainage of the peritoneal omental sac, abdomen and retroperitoneal space, 5 patients – endoscopic 
retrograde cholangiopancreatography (ERCP) with drainage of biliary ducts, 2 patients – endoscopic stenting of the 
pancreatic ducts.  In 4 (10.2%) patients, CP was associated with previous surgeries on the organs of the pancreatobiliary 
area: 2 patients underwent cholecystectomy due to cholelithiasis, and 2 patients underwent Bilroth II gastrectomy due to 
duodenal ulcer. In 14 (35.9%) patients their condition was probably caused by cigarette smoking. In 8 (20.5 %) patients, 
a direct connection between CP and regular alcohol consumption was established. In 7 patients, the causes of CP 
complicated by BH were not found, and in these cases CP was qualified as idiopathic. Acute destructive pancreatitis is 
often an etiological factor in the development of CP complicated by BH. BH in case of CP is one of the absolute 
indications for surgical treatment, and the method of BH correction should be determined individually. 
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 Problem statement and analysis of the recent research 
Chronic pancreatitis is a group of chronic diseases of the pancreas of different etiology (mostly of inflammatory 
origin) that are characterized by phase-progressing segmental or diffuse degenerative, destructive changes in the exocrine 
pancreas; atrophy of glandular elements and their replacement by connective tissue (fibrosis), the development of which 
determines the rate of progression of the disease in general; changes in the pancreatic duct system with further formation 
of cysts and concrements; different degrees of decline in exocrine and endocrine function of the pancreas; development 
of complications at any stage of the disease (early, middle, and late) [10]. 
 According to autopsy data, the incidence of CP is 0.01 to 5.4%, on average – 0.3–0.4%. The incidence of this 
pathology is constantly growing due to alcohol consumption, and frequency of its detection is increasing due to the 
improvement of the diagnostic methods; the percentage of alcohol-induced pancreatitis increased from 40% to 75% [2]. 
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develop in 70-85% of cases. 6.3% of patients with CP die within 5 years, 30% of patients with CP die within 10 years, 
and 50% of patients with CP die within 20 years.   
 CP is a pluricausal disease; many factors are involved in its development. They include acute pancreatitis, long-
term alcohol abuse, smoking, high-fat and protein diets, disorders of the gall bladder and bile ducts, diseases of the 
papillary and peripapillary areas, duodenum, hereditary factors, etc. 
 In 65-70% of cases CP is associated with alcohol abuse. The total mortality rate due to CP among patients with 
alcohol-induced pancreatitis suffering from this disease for over 20 years is 28.8% to 35.0% [18]. Long-term heavy 
alcohol consumption (prolonged daily intake of 80g of pure ethanol at a dose of 80g or more) is an important etiological 
factor. However, consumption of less amount of alcohol may also contribute to the development of CP, especially when 
other risk factors are present [2]. The combination of smoking and heavy drinking increases the risk for the disease. 
However, there is no absolute link between alcohol drinking and CP. It remains unclear why only 10% of alcohol addicts 
develop clinical signs of CP [2]  
 An important independent risk factor in the development of CP is smoking, which contributes to pancreatic 
calcification and exocrine insufficiency [5, 8, 12]. 
 The development of CP is often a result of acute pancreatitis, the transition of which into chronic stage is due to 
pancreatic duct obstruction (stenosis, calculi, and pseudocysts) and fibrotic process in the pancreas. Recurring and severe 
acute pancreatitis cause approximately 6% of CP cases [13]. The research published in scientific journal “Pancreas” 
(2011) [16] analyzed transition of acute pancreatitis into CP in 352 patients. The findings showed that acute pancreatitis 
transformed into CP in 85 (24%) patients, whereas in 48% of patients the genesis of the disease was found to be alcoholic, 
in 47% of patients it was idiopathic, and in 5% of patients rare forms were detected. Mortality rate in this group of patients 
was 2.7 times higher than in patients without similar transition. 
 An important role in CP development is played by a high-fat and high-protein diet [5, 8, 11, 12]. Disorders of 
the gall bladder and bile ducts, mainly gallstone disease in the form of choledocholithiasis, are of etiological importance 
primarily in women [1, 4]. Diseases of the papillary and peripapillary areas of the duodenum (sphincter of Oddi 
dysfunction, posttraumatic cicatrical strictures of the pancreatic ducts, papillitis, diverticula, etc.) are also frequent causes 
of CP development [10]. 
 Hereditary factors also play an important role in CP development. There are three types of genetic variations 
associated with mutations. They include cystic fibrosis gene (CFTR), cationic trypsinogen gene (PRSS1), pancreatic 
secretory trypsin inhibitor (SPINK1) gene [7, 9, 18]. Genetically determined hereditary CP takes up approximately 1% 
in the general structure of this nosology [14]. This CP type is determined on the basis of researching mutations of PRSS1, 
SPINK 1, PRSS2, and CFTR genes in persons, whose family members (two or more) had or have CP in more than one 
generation [15]. The main distinction of hereditary CP is its manifestation in patients under 20 years and in many cases 
even in childhood [18]. 
 In other cases CP is classified as idiopathic (20-25%) including factors such as tropical pancreatitis, which is the 
main cause of CP development in children in tropical regions, metabolic imbalance, autoimmune disorders, etc. [17]. 
Most often, CP is accompanied by functional disorders of the biliary tract with further development of 
manifestative or non-manifestative BH which occurs in 25-40% of cases. A common cause of jaundice in CP is tubular 
stenosis of the bile duct caused by pancreatic fibrosis and inflammation in the head of the pancreas [17]. Common bile 
duct obstruction is found in 56.3% of patients with CP, jaundice is detected in 22.2%, and 6% of patients develop jaundice 
with co-existent cholangitis [3]. A significant role in the development of obstructive jaundice in CP is also played by 
constriction of the distal part of the common bile duct by fibrotically changed pancreatic lingula [6].  
The objective of the research was to study the causes of the development of chronic pancreatitis complicated by 
biliary hypertension.  
 
Materials and methods  
During the 2009-2015 time period, 127 patients with complicated forms of chronic pancreatitis (CP) underwent 
surgical treatment at the Department of General Surgery of the Ivano-Frankivsk Regional Clinical Hospital. CP was 
accompanied by BH in 39 (30.7%) patients. 14 (11.1%) patients developed BH with concomitant CDO, and in 4 (3.1%) 
patients a combination of BH+CDO and local venous hypertension (VH) of the vessels in the pancreatobiliary area was 
found. The dilatation of the portal vein diameter by over 1.1-1.3 cm during US indicated VH; additional VH signs included 
megalosplenia (2 patients) and gastric varices (1 patient). There were 36 (92.3 %) men and 3 (7.7 %) women at the age 
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Except laboratory data, US, ERCP, and contrast-enhanced CT were of most practical importance for diagnosing 
changes in the pancreas, pancreatic duct, and adjacent organs. In the course of research, the classification of CP suggested 
by academician O. O. Shalimov (1997) was used.  
 
Results and discussion 
In all 39 patients tubular stenosis of the intrapancreatic part of the choledoch was the morphological substrate of 
BH due to fibrose-degenerative changes in the pancreatic head; in 9 (23.1%) patients it was combined with cysts of the 
pancreatic head. In 28 (71.7%) patients, BH had clinical signs (ochrodermia and mucosal icterus, hyperbilirubinemia), 
and in 11 (28.9%) patients BH was asymptomatic and was diagnosed only by means of USG and CT (tubular stenosis 
and dilation of the suprapancreatic segment of the common bile duct 0.7 cm to 1.3-1.5 cm). In 3 (7.6%) patients, BH was 
accompanied by the manifestations of cholangitis. 
The results of USG indicated local or diffuse enlargement of the head of the pancreas from 3.5 to 5.7 cm in all 
patients with BH and heterogeneity of pancreatic tissue in 25 (64.1%) patients. Calcifications in glandular tissue were 
found in 11 (28.2%) patients. Dilatation of the pancreatic duct by over 5 mm was detected in 12 (30.7%) patients, and 
Lithiasis of Wirsung's duct was found in 5 (12.8%) patients.  
All patients with CP complicated by BH underwent surgical treatment.  The development of BH in CP was 
considered to be a certain indication for surgical treatment. Drainage, resection, and combined surgical interventions were 
used. The method of BH correction was determined for each individual case. 
General characteristics of performed surgeries are presented in Table 1. 
 
Table 1 
General characteristics of surgical interventions in patients with chronic pancreatitis complicated by biliary hypertension 
Surgery Number % 
Pancreaticoduodenal resection (Whipple procedure) 5 12.8 
Frey’s procedure 11 28.3 
including choledochoenteroanastomosis 2 5.1 
including insertion according to V. Kopchak and 
choledochoenteroanastomosis 
2 5.1 
Bern modification of Beger procedure 2 5.1 
Longitudinal pancreaticojejunostomy 8 20.5 
including choledochoenteroanastomosis 3 7.7 
including insertion according to V. Kopchak and 
choledochoenteroanastomosis 
1 2.6 
Cystoenterotomy 3 7.7 
including choledochoenteroanastomosis 2 5.1 
Endoscopic cystoduodenostomy 2 5.1 
Application of biliodigestive bypass	anastomoses 2 5.1 
External drainage of pancreatic cyst 1 2.6 
ERCP with endobiliary stenting 5 12.8 
Total 39 100.0 
 
	 In 17 (43.5%) patients CP complicated by BH was the result of acute pancreatitis (1 to 10 years ago), 14 of them 
underwent surgeries: 2 patients – laparoscopic drainage of the enzymatic peritonitis, 5 patients – laparotomy, drainage of 
the peritoneal omental sac, abdomen and retroperitoneal space, 5 patients – endoscopic retrograde 
cholangiopancreatography (ERCP) with drainage of biliary ducts, 2 patients – endoscopic stenting of the pancreatic ducts.  
Other 3 patients were treated conservatively. 
In 4 (10.2%) patients CP was associated with previous surgeries on the organs of the pancreatobiliary area: 2 
patients underwent cholecystectomy due to cholelithiasis, and 2 patients underwent Bilroth II gastrectomy due to 
duodenal ulcer. These patients did not abuse alcohol and smoke. 
 In 14 (35.9%) patients their condition was probably caused by regular tobacco use. In 8 (20.5 %) patients a direct 
connection between CP and regular alcohol consumption was determined. However, not all patients were honest when 
answering this question. In 7 patients heavy alcohol consumption was combined with smoking. The majority of these 
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In 7 patients, the causes of CP complicated by BH were not found. There were determined neither hereditary 




1. Acute destructive pancreatitis is the most often etiological factor in the development of CP complicated by 
BH. 
2. BH in case of CP is one of the absolute indications for surgical treatment, and the method of BH correction 
should be determined individually. 
 
Prospects for further research 
The prospects for further research consist in further study of causes of the development of CP complicated by 
BH, and elaboration of measures of its prevention. 
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